UM Doctoral Student Develops Novel Drug Molecules to Target Osteoporosis

Annie Buchholz, a pharmaceutical sciences Ph.D. candidate at the University of Montana, used a French fellowship to help design a new class of molecules that eliminate — rather than merely block — an enzyme linked to bone loss.